{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:22:02Z","timestamp":1790626922106,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T00:00:00Z","timestamp":1381190400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s00296-013-2875-0","type":"journal-article","created":{"date-parts":[[2013,10,7]],"date-time":"2013-10-07T11:21:50Z","timestamp":1381144910000},"page":"617-623","source":"Crossref","is-referenced-by-count":32,"title":["Higher circulating levels of OxLDL % of LDL are associated with subclinical atherosclerosis in female patients with systemic lupus erythematosus"],"prefix":"10.1007","volume":"34","author":[{"given":"Hamada Mohammad","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmat M.","family":"Sarhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usama","family":"Komber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,8]]},"reference":[{"issue":"7","key":"2875_CR1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrrheum.2011.75","volume":"7","author":"DP Symmons","year":"2011","unstructured":"Symmons DP, Gabriel SE (2011) Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 7(7):399\u2013408","journal-title":"Nat Rev Rheumatol"},{"key":"2875_CR2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/ard.59.5.321","volume":"59","author":"S Manzi","year":"2000","unstructured":"Manzi S, Wasko NCM (2000) Inflammation mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis 59:321\u2013325","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2875_CR3","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","volume":"145","author":"S Manzi","year":"1997","unstructured":"Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, D\u2019Agostino RB, Kuller LH (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 145(5):408\u2013415","journal-title":"Am J Epidemiol"},{"key":"2875_CR4","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/art.23196","volume":"58","author":"T Thompson","year":"2008","unstructured":"Thompson T, Sutton-Tyrrell K, Wildman RP et al (2008) Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus. Arthritis Rheum 58:835\u2013842","journal-title":"Arthritis Rheum"},{"issue":"10","key":"2875_CR5","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","volume":"44","author":"JM Esdaile","year":"2001","unstructured":"Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, C\u00f4te R, Grover SA, Fortin PR, Clarke AE, Sen\u00e9cal JL (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44(10):2331\u20132337","journal-title":"Arthritis Rheum"},{"key":"2875_CR6","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1096\/fj.01-0273rev","volume":"15","author":"A Mertens","year":"2001","unstructured":"Mertens A, Holvoet P (2001) Oxidized LDL and HDL: antagonists in atherothrombosis. FASEB J 15:2073\u20132084","journal-title":"FASEB J"},{"issue":"3 Suppl","key":"2875_CR7","first-page":"765S","volume":"136","author":"BH Lau","year":"2006","unstructured":"Lau BH (2006) Suppression of LDL oxidation by garlic compounds is a possible mechanism of cardiovascular health benefit. J Nutr 136(3 Suppl):765S\u2013768S","journal-title":"J Nutr"},{"issue":"1","key":"2875_CR8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1073\/pnas.76.1.333","volume":"76","author":"JL Goldstein","year":"1979","unstructured":"Goldstein JL, Ho YK, Basu SK, Brown MS (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76(1):333\u2013337","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2875_CR9","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1073\/pnas.81.12.3883","volume":"81","author":"UP Steinbrecher","year":"1984","unstructured":"Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D (1984) Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 81(12):3883\u20133887","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"2875_CR10","doi-asserted-by":"crossref","first-page":"11305","DOI":"10.1016\/S0021-9258(18)90863-X","volume":"259","author":"ME Haberland","year":"1984","unstructured":"Haberland ME, Olch CL, Folgelman AM (1984) Role of lysines in mediating interaction of modified low density lipoproteins with the scavenger receptor of human monocyte macrophages. J Biol Chem 259(18):11305\u201311311","journal-title":"J Biol Chem"},{"key":"2875_CR11","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/01.ATV.0000080379.05071.22","volume":"23","author":"P Holvoet","year":"2003","unstructured":"Holvoet P, Harris TB, Tracy RP, Verhamme P, Newman AB, Rubin SM, Simonsick EM, Colbert LH, Kritchevsky SB (2003) Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the Health, Aging and Body Composition study. Arterioscler Thromb Vasc Biol 23:1444\u20131448","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"2875_CR12","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725","journal-title":"Arthritis Rheum"},{"issue":"12","key":"2875_CR13","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.2337\/diacare.27.12.2887","volume":"27","author":"ED Beishuizen","year":"2004","unstructured":"Beishuizen ED, van de Ree MA, Jukema JW, Tamsma JT, van der Vijver JC, Meinders AE, Putter H, Huisman MV (2004) Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease. Diabetes care 27(12):2887\u20132892","journal-title":"Diabetes care"},{"issue":"9","key":"2875_CR14","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69(9):1580\u20131588","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2875_CR15","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288\u2013291","journal-title":"J Rheumatol"},{"key":"2875_CR16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00044011-200020020-00001","volume":"20","author":"TJ Smilde","year":"2000","unstructured":"Smilde TJ, Trip MD, Wollersheim H, van Wissen S, Kastelein JJP, Stalenhoef AFH (2000) Rationale, design and baseline characteristics of a clinical trial comparing the effects of robust vs conventional cholesterol lowering and intima media thickness in patients with familial hypercholesterolaemia. Clin Drug Invest 20:67\u201379","journal-title":"Clin Drug Invest"},{"issue":"5","key":"2875_CR17","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/ajcp\/66.5.840","volume":"66","author":"CL Fischer","year":"1976","unstructured":"Fischer CL, Gill C, Forrester MG, Nakamura R (1976) Quantitation of \u201cacute-phase proteins\u201d postoperatively. Value in detection and monitoring of complications. Am J Clin Pathol 66(5):840\u2013846","journal-title":"Am J Clin Pathol"},{"key":"2875_CR18","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.2337\/diacare.23.11.1679","volume":"23","author":"R Boizel","year":"2000","unstructured":"Boizel R, Benhamou PY, Lardy B, Laporte F, Foulon T, Halimi S (2000) Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care 23:1679\u20131685","journal-title":"Diabetes Care"},{"key":"2875_CR19","doi-asserted-by":"crossref","unstructured":"Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Jaff M, Kownator S, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS, Zannad F, Zureik M (2007) Mannheim Carotid Intima-Media Thickness Consensus (2004\u20132006). An update on behalf of the advisory board of the 3rd and 4th watching the risk symposium 13th and 15th European stroke conferences, Mannheim, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 23:75\u201380","DOI":"10.1159\/000097034"},{"issue":"4","key":"2875_CR20","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2337\/diabetes.53.4.1068","volume":"53","author":"P Holvoet","year":"2004","unstructured":"Holvoet P, Kritchevsky SB, Tracy RP, Mertens A, Rubin SM, Butler J, Goodpaster B, Harris TB (2004) The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes 53(4):1068\u20131073","journal-title":"Diabetes"},{"issue":"105","key":"2875_CR21","first-page":"1135","volume":"5","author":"P Libby","year":"2005","unstructured":"Libby P, Ridker PM, Maseri A (2005) Inflammation and atherosclerosis. Circulation 5(105):1135\u20131143","journal-title":"Circulation"},{"key":"2875_CR22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1046\/j.1365-2796.2002.01054.x","volume":"252","author":"V Sigurdardottir","year":"2002","unstructured":"Sigurdardottir V, Fagerberg B, Hulthe J (2002) Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study). J Intern Med 252:440\u2013447","journal-title":"J Intern Med"},{"key":"2875_CR23","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/01.ATV.19.3.810","volume":"19","author":"L Chancharme","year":"1999","unstructured":"Chancharme L, Therond P, Nigon F, Lepage S, Couturier M, Chapman MJ (1999) Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL. Arterioscler Thromb Vasc Biol 19:810\u2013820","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2875_CR24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/01.CIR.0000055014.62083.05","volume":"107","author":"PM Ridker","year":"2003","unstructured":"Ridker PM, Buring JE, Cook NR, Rifai N (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 107:391\u2013397","journal-title":"Circulation"},{"key":"2875_CR25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/VHRM.S17015","volume":"7","author":"SO Olusi","year":"2011","unstructured":"Olusi SO, George S (2011) Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus. Vasc Health Risk Manag 7:75\u201380","journal-title":"Vasc Health Risk Manag"},{"issue":"3","key":"2875_CR26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11883-007-0026-3","volume":"9","author":"M Navab","year":"2007","unstructured":"Navab M, Yu R, Gharavi N, Huang W, Ezra N, Lotfizadeh A, Anantharamaiah GM, Alipour N, Van Lenten BJ, Reddy ST, Marelli D (2007) High-density lipoprotein: antioxidant and antiinflammatory properties. Curr Atheroscler Rep 9(3):244\u2013248","journal-title":"Curr Atheroscler Rep"},{"issue":"22","key":"2875_CR27","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1161\/01.CIR.0000103624.14436.4B","volume":"108","author":"BJ Ansell","year":"2003","unstructured":"Ansell BJ, Navab M, Hama S, Kamranpour N, Fonarow G, Hough G, Rahmani S, Mottahedeh R, Dave R, Reddy ST, Fogelman AM (2003) Inflammatory\/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation 108(22):2751\u20132756","journal-title":"Circulation"},{"issue":"12","key":"2875_CR28","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1194\/jlr.M700176-JLR200","volume":"48","author":"SI Leuven van","year":"2007","unstructured":"van Leuven SI, Hezemans R, Levels JH, Snoek S, Stokkers PC, Hovingh GK, Kastelein JJ, Stroes ES, de Groot E, Hommes DW (2007) Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn\u2019s disease. J Lipid Res 48(12):2640\u20132646","journal-title":"J Lipid Res"},{"issue":"1","key":"2875_CR29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijcard.2007.12.019","volume":"129","author":"S Dodani","year":"2008","unstructured":"Dodani S, Kaur R, Reddy S, Reed GL, Navab M, George V (2008) Can dysfunctional HDL explain high coronary artery disease risk in South Asians? Int J Cardiol 129(1):125\u2013132","journal-title":"Int J Cardiol"},{"key":"2875_CR30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/ar2471","volume":"10","author":"BH Hahn","year":"2008","unstructured":"Hahn BH, Grossman J, Ansell BJ, Skaggs BJ, McMahon M (2008) Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthr Res Ther 10:213","journal-title":"Arthr Res Ther"},{"key":"2875_CR31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1203\/00006450-199901000-00016","volume":"45","author":"L Iughetti","year":"1999","unstructured":"Iughetti L, Volta C, Maggi E et al (1999) Circulating antibodies recognizing oxidatively modified low-density lipoprotein in children. Pediatr Res 45:94\u201399","journal-title":"Pediatr Res"},{"key":"2875_CR32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1161\/01.HYP.33.1.53","volume":"33","author":"R Wu","year":"1999","unstructured":"Wu R, de Faire U, Lemne C et al (1999) Autoantibodies to OxLDL are decreased in individuals with borderline hypertension. Hypertension 33:53\u201359","journal-title":"Hypertension"},{"key":"2875_CR33","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/01.ATV.20.3.703","volume":"20","author":"M Fukumoto","year":"2000","unstructured":"Fukumoto M, Shoji T, Emoto M et al (2000) Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population. Arterioscler Thromb Vasc Biol 20:703\u2013707","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2875_CR34","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1196\/annals.1398.036","volume":"1109","author":"LR Lopez","year":"2007","unstructured":"Lopez LR, Buckner TR, Hurkey BL, Kobayashi BL, Matsuura E (2007) Determination of oxidized low-density lipoproteins (ox-LDL) versus ox-LDL\/\u03b22GPI complexes for the assessment of autoimmune-mediated atherosclerosis. Ann NY Acad Sci 1109:303\u2013310","journal-title":"Ann NY Acad Sci"},{"key":"2875_CR35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.autrev.2007.06.003","volume":"7","author":"N Bassi","year":"2007","unstructured":"Bassi N, Ghirardello A, Iaccarino L, Zampieri S, Rampudda ME, Atzeni F, Sarzi-Puttini P, Shoenfeld Y, Doria A (2007) OxLDL\/[beta]2GPI-anti-OxLDL\/[beta]2GPI complex and atherosclerosis in SLE patients. Autoimmun Rev 7:52\u201358","journal-title":"Autoimmun Rev"},{"key":"2875_CR36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0002-9343(92)90578-Y","volume":"93","author":"M Petri","year":"1992","unstructured":"Petri M, Perez-Gutthann S, Spence D, Hochberg MC (1992) Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 93:513\u2013519","journal-title":"Am J Med"},{"key":"2875_CR37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00005792-199209000-00004","volume":"71","author":"M Petri","year":"1992","unstructured":"Petri M, Sepnce D, Bone LR, Hochberg MC (1992) Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices. Medicine (Baltimore) 71:291\u2013302","journal-title":"Medicine (Baltimore)"},{"issue":"25","key":"2875_CR38","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","volume":"349","author":"MJ Roman","year":"2003","unstructured":"Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, Crow MK, Schwartz JE, Paget SA, Devereux RB, Salmon JE (2003) Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349(25):2399\u20132406","journal-title":"N Engl J Med"},{"key":"2875_CR39","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1002\/art.20612","volume":"50","author":"HM Kremers","year":"2004","unstructured":"Kremers HM, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2004) Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum 50:3450\u20133457","journal-title":"Arthritis Rheum"},{"key":"2875_CR40","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/ard.2003.018101","volume":"63","author":"C Turesson","year":"2004","unstructured":"Turesson C, Jarenros A, Jacobsson L (2004) Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann Rheum Dis 63:952\u2013955","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2875_CR41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/CIRCULATIONAHA.105.575241","volume":"113","author":"A Khera","year":"2006","unstructured":"Khera A, de Lemos JA, Peshock RM, Lo HS, Stanek HG, Murphy SA, Wians FH Jr, Grundy SM, McGuire DK (2006) Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation 113(1):38\u201343","journal-title":"Circulation"},{"issue":"11","key":"2875_CR42","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/rheumatology\/ker285","volume":"50","author":"AN Kiani","year":"2011","unstructured":"Kiani AN, Post WS, Magder LS, Petri M (2011) Predictors of progression in atherosclerosis over 2\u00a0years in systemic lupus erythematosus. Rheumatology (Oxford) 50(11):2071\u20132079","journal-title":"Rheumatology (Oxford)"},{"key":"2875_CR43","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1002\/art.21397","volume":"52","author":"I Rinc\u00f3n del","year":"2005","unstructured":"del Rinc\u00f3n I, Freeman GL, Haas RW, O\u2019Leary DH, Escalante A (2005) Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum 52:3413\u20133423","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2875_CR44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/rheumatology\/ker307","volume":"51","author":"J Romero-D\u00edaz","year":"2012","unstructured":"Romero-D\u00edaz J, Vargas-V\u00f3rackov\u00e1 F, Kimura-Hayama E, Cort\u00e1zar-Ben\u00edtez LF, Gij\u00f3n-Mitre R, Criales S, Cabiedes-Contreras J, I\u00f1iguez-Rodr\u00edguez Mdel R, Lara-Garc\u00eda EA, N\u00fa\u00f1ez-Alvarez C, Llorente L, Aguilar-Salinas C, S\u00e1nchez-Guerrero J (2012) Systemic lupus erythematosus risk factors for coronary artery calcifications. Rheumatology (Oxford) 51(1):110\u2013119","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"2875_CR45","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","volume":"69","author":"MJ Peters","year":"2010","unstructured":"Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69(2):325","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2875-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-013-2875-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2875-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T03:57:37Z","timestamp":1646711857000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-013-2875-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,8]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["2875"],"URL":"https:\/\/doi.org\/10.1007\/s00296-013-2875-0","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,8]]}}}